126 related articles for article (PubMed ID: 20683410)
1. Association between serum cytokine profiles and clearance or persistence of high-risk human papillomavirus infection: a prospective study.
Hong JH; Kim MK; Lee IH; Kim TJ; Kwak SH; Song SH; Lee JK
Int J Gynecol Cancer; 2010 Aug; 20(6):1011-6. PubMed ID: 20683410
[TBL] [Abstract][Full Text] [Related]
2. Clearance and persistence of the human papillomavirus infection among Cameroonian women.
Akaaboune M; Kenfack B; Viviano M; Temogne L; Catarino R; Tincho E; Mbobda J; Tran PL; Camail R; Vassilakos P; Petignat P
Womens Health (Lond); 2018; 14():1745506518805642. PubMed ID: 30353785
[TBL] [Abstract][Full Text] [Related]
3. Persistence and clearance of human papillomavirus infection: a prospective cohort study.
Rosa MI; Fachel JM; Rosa DD; Medeiros LR; Igansi CN; Bozzetti MC
Am J Obstet Gynecol; 2008 Dec; 199(6):617.e1-7. PubMed ID: 18799155
[TBL] [Abstract][Full Text] [Related]
4. A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
Torres-Poveda K; Bahena-Román M; Delgado-Romero K; Madrid-Marina V
BMC Infect Dis; 2018 Nov; 18(1):582. PubMed ID: 30453958
[TBL] [Abstract][Full Text] [Related]
5. Natural history of persistent high-risk human papillomavirus infections in Korean women.
Bae J; Seo SS; Park YS; Dong SM; Kang S; Myung SK; Park SY
Gynecol Oncol; 2009 Oct; 115(1):75-80. PubMed ID: 19619893
[TBL] [Abstract][Full Text] [Related]
6. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV).
Song SH; Lee JK; Lee NW; Saw HS; Kang JS; Lee KW
Gynecol Oncol; 2008 Mar; 108(3):543-8. PubMed ID: 18164379
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
9. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
Plummer M; Schiffman M; Castle PE; Maucort-Boulch D; Wheeler CM;
J Infect Dis; 2007 Jun; 195(11):1582-9. PubMed ID: 17471427
[TBL] [Abstract][Full Text] [Related]
10. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
11. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?
Agorastos T; Chrisafi S; Lambropoulos AF; Mikos T; Constandinides TC; Schlehofer JR; Schlehofer B; Kotsis A; Bontis JN
Eur J Cancer Prev; 2008 Aug; 17(4):364-8. PubMed ID: 18562963
[TBL] [Abstract][Full Text] [Related]
13. Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens.
Kapala J; Jang D; Patel J; Biers K; Smieja M; Chernesky M
J Virol Methods; 2007 Jun; 142(1-2):223-5. PubMed ID: 17320978
[TBL] [Abstract][Full Text] [Related]
14. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
15. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
16. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.
Inoue M; Sakaguchi J; Sasagawa T; Tango M
Int J Gynecol Cancer; 2006; 16(3):1007-13. PubMed ID: 16803477
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
19. Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA⁺ and DNA⁻ cervical lesions.
Ali KS; Ali HY; Jubrael JM
J Immunotoxicol; 2012; 9(2):168-72. PubMed ID: 22471745
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.
Waisberg MG; Ribeiro AC; Candido WM; Medeiros PB; Matsuzaki CN; Beldi MC; Tacla M; Caiaffa-Filho HH; Bonfa E; Silva CA
Rheumatol Int; 2015 Mar; 35(3):459-63. PubMed ID: 25348220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
